Protagonist Therapeutics Inc
Protagonist Therapeutics Inc logo
PTGX

Protagonist Therapeutics Inc (PTGX)

$7.681.54%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$7.6125
Day's Range
$7.8
$6.91
52-Week Range
$37.05
1 month return0.9%
3 month return12.93%
1 year return77.29%
5 year return60.21%

Company Information

Protagonist Therapeutics is a clinical stage biopharmaceutical company with multiple peptide-based new chemical entities in different stages of development. Rusfertide (PTG-300) is an injectable hepcidin mimetic in a Phase 2 proof-of-concept clinical trial for polycythemia vera, and a separate Phase 2 clinical study for hereditary hemochromatosis. PN-943 is an orally delivered, gut-restricted alpha-4-beta-7 integrin specific antagonist peptide in a 150 patient Phase 2 study for the potential treatment of inflammatory bowel disease, with ulcerative colitis as the initial targeted indication. PTG-200 is an orally delivered, gut-restricted, interleukin-23 receptor specific antagonist peptide in a Phase 2 clinical trial for Crohn's disease. Two additional second-generation oral interleukin-23 receptor antagonist candidates PN-235 and PN-232, are in early stages of clinical development. The Company has developed a proprietary technology platform to discover and develop novel peptide-based therapeutics to address significant unmet medical needs and transform existing treatment paradigms.
OrganizationProtagonist Therapeutics Inc
Employees118
CEODr. Dinesh V. Patel Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for Protagonist Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 329.69%

Current

$7.68

Target

$33.0

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
7
12
11
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
393.1M
Book Value
$4.95
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.58
PEG Ratio
0.0
Wall Street Target Price
33.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.63
Enterprise Value
133.8M
Enterprise Value/Revenue
3.8
Enterprise Value/Ebitda
-1.04

Technicals

Beta
2.34
50 Day MA
8.15
200 Day MA
12.34

Institutional Holdings

State Street Corporation

9.51%

RTW INVESTMENTS, LLC

8.49%

Farallon Capital Management, L.L.C.

7.42%

FMR Inc

7.1%

BlackRock Inc

7.04%

Vanguard Group Inc

5.98%

Discover more

Frequently Asked Questions

What is Protagonist Therapeutics Inc share price today?

Can Indians buy Protagonist Therapeutics Inc shares?

How can I buy Protagonist Therapeutics Inc shares from India?

Can Fractional shares of Protagonist Therapeutics Inc be purchased?

What are the documents required to start investing in Protagonist Therapeutics Inc stocks?

What are today’s High and Low prices of Protagonist Therapeutics Inc?

What are today’s traded volumes of Protagonist Therapeutics Inc?

What is today’s market capitalisation of Protagonist Therapeutics Inc?

What is the 52 Week High and Low Range of Protagonist Therapeutics Inc?

How much percentage Protagonist Therapeutics Inc is down from its 52 Week High?

How much percentage Protagonist Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Protagonist Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Protagonist Therapeutics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*